Physiological Reviews, Vol 68, 85-132, Copyright © 1988 by American Physiological Society

JOURNAL ARTICLE

Apolipoprotein genetic variation and human disease

J. L. Breslow
Rockefeller University, New York, New York.

Atherosclerosis is the major public health problem in much of the world today. The information summarized in this review, based on the recognized apolipoprotein structural variants appreciated at both the protein and gene levels, indicates that apolipoprotein genetic variation plays a major role in determining human genetic susceptibility to this disease. With the use of cloned apolipoprotein genes, it should, in the near future, be possible to determine how their expression is regulated; this should provide insight into other classes of mutations of a regulatory nature that might have clinical significance. In addition, the many association and linkage studies currently being undertaken will provide the rationale for cloning defective alleles and determining specific causative mutations. Both structural and regulatory mutations can then be described either with restriction enzymes and Southern blotting or by direct oligonucleotide hybridization techniques in the general population. This will allow the identification of presymptomatic atherosclerosis-susceptible individuals who would be targets for primary preventative therapy.

This article has been cited by other articles:

				H. Coon, M. F. Leppert, J. H. Eckfeldt, A. Oberman, R. H. Myers, J. M. Peacock, M. A. Province, P. N. Hopkins, and G. Heiss Genome-Wide Linkage Analysis of Lipids in the Hypertension Genetic Epidemiology Network (HyperGEN) Blood Pressure Study Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1969 - 1976. [Abstract] [Full Text] [PDF]

				J.-P. Wang, M. Enjoji, M. Tiebel, S. Ochsner, L. Chan, and B.-B. Teng Hammerhead Ribozyme Cleavage of Apolipoprotein B mRNA Generates a Truncated Protein J. Biol. Chem., August 20, 1999; 274(34): 24161 - 24170. [Abstract] [Full Text] [PDF]

				R. E. Olson Discovery of the Lipoproteins, Their Role in Fat Transport and Their Significance as Risk Factors J. Nutr., February 1, 1998; 128(2): 439 - 439. [Abstract] [Full Text]

				B Teng, C. Burant, and N. Davidson Molecular cloning of an apolipoprotein B messenger RNA editing protein Science, June 18, 1993; 260(5115): 1816 - 1819. [Abstract] [PDF]

				R Rapley, S Flora, and M R Walker Direct PCR sequencing of murine immunoglobulin genes using E. coli single-stranded DNA-binding protein. Genome Res., August 1, 1992; 2(1): 99 - 101. [PDF]

				F M Sladek, W M Zhong, E Lai, and J E Darnell Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes & Dev., December 1, 1990; 4(12b): 2353 - 2365. [Abstract] [PDF]

				D Gavish, E. Brinton, and J. Breslow Heritable allele-specific differences in amounts of apoB and low-density lipoproteins in plasma Science, April 7, 1989; 244(4900): 72 - 76. [Abstract] [PDF]

				V. Blanc, N. Navaratnam, J. O. Henderson, S. Anant, S. Kennedy, A. Jarmuz, J. Scott, and N. O. Davidson O|Identification of GRY-RBP as an Apolipoprotein B RNA-binding Protein That Interacts with Both Apobec-1 and Apobec-1 Complementation Factor to Modulate C to U Editing J. Biol. Chem., March 23, 2001; 276(13): 10272 - 10283. [Abstract] [Full Text] [PDF]